Renal arterioles in patients with type I diabetes and microalbuminuria before and after treatment with antihypertensive drugs

被引:7
作者
Gulmann, C
Rudberg, S
Osterby, R
机构
[1] Aarhus Univ Hosp, Inst Pathol, Electron Microscopy Lab, DK-8000 Aarhus C, Denmark
[2] Karolinska Inst, Dept Women & Child Hlth, Paediat Unit, Stockholm, Sweden
关键词
type I diabetes; diabetic nephropathy; microalbuminuria; arteriolar hyalinosis; ACE inhibitors; antihypertensive treatment; stereology;
D O I
10.1007/s004280050378
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Antihypertensive drugs can slow or even reverse the progression of diabetic nephropathy at the microalbuminuric stage. This study was performed to obtain quantitative data on changes in the renal arterioles in a follow-up study. Twelve patients with type I diabetes and with microalbuminuria were allocated to treatment for 3 years with either an ACE inhibitor (group I, 6 patients) or a beta blocker (group II, 6 patients). Baseline and follow-up renal needle biopsy specimens were taken and serially sectioned at 1 mu m for light microscopy, enabling identification of arterioles as afferent or efferent. Thin sections for electron microscopy were made at 50-mu m intervals, and micrographs were taken of arteriolar profiles. Matrix volume fraction of the media and a calculated matrix thickness were obtained. At baseline, structural parameters were higher than normal values. At follow-up all patients were normoalbuminuric. Both groups showed only minor changes in arteriolar structures over 3 years. In the afferent arterioles in group II there was a significant increase in the matrix volume fraction of the media, and there was a tendency to an increase in matrix thickness in both groups. In the efferent arterioles there were no significant changes in parameters. There were no differences between the two groups in arteriolar structural changes from baseline to follow-up. Thus. this study shows a slight but significant matrix accumulation in the afferent arterioles during treatment with antihypertensive drugs. This may have implications for the progression to overt nephropathy, which indicates a need for more long-term studies of treatment with antihypertensive drugs in incipient nephropathy in type I diabetes.
引用
收藏
页码:523 / 528
页数:6
相关论文
共 22 条
[11]  
HASSLACHER C, 1993, CLIN INVESTIGATOR, V71, pS20
[12]   WASSERRUCKRESORPTION UND IONENTRANSPORT DURCH DIE SAMMELROHRZELLEN DER SAUGETIERNIERE (MIKROANALYTISCHE UNTERSUCHUNGEN) [J].
HILGER, HH ;
KLUMPER, JD ;
ULLRICH, KJ .
PFLUGERS ARCHIV FUR DIE GESAMTE PHYSIOLOGIE DES MENSCHEN UND DER TIERE, 1958, 267 (03) :218-237
[13]   PREVENTION OF DIABETIC NEPHROPATHY WITH ENALAPRIL IN NORMOTENSIVE DIABETICS WITH MICROALBUMINURIA [J].
MARRE, M ;
CHATELLIER, G ;
LEBLANC, H ;
GUYENE, TT ;
MENARD, J ;
PASSA, P .
BMJ-BRITISH MEDICAL JOURNAL, 1988, 297 (6656) :1092-1095
[14]  
OLSEN S, 1997, KIDNEY HYPERTENSION, P173
[15]  
OSTERBY R, 1995, DIABETOLOGIA, V38, P1320
[16]  
ROSIVALL L, 1990, KIDNEY INT, V38, pS10
[17]   Predictors of renal morphological changes in the early stage of microalbuminuria in adolescents with IDDM [J].
Rudberg, S ;
Osterby, R ;
Dahlquist, G ;
Nyberg, G ;
Persson, B .
DIABETES CARE, 1997, 20 (03) :265-271
[18]  
TEPPO AM, 1982, CLIN CHEM, V28, P1359
[19]   EFFECT OF CAPTOPRIL ON PROGRESSION TO CLINICAL PROTEINURIA IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS AND MICROALBUMINURIA [J].
VIBERTI, G ;
MOGENSEN, CE ;
GROOP, LC ;
PAULS, JF ;
BONER, G ;
VANDYK, DJ ;
LUCAS, A ;
ROMERO, R ;
SALINAS, I ;
SANMARTI, A ;
BLOMQVIST, AC ;
EKSTRAND, A ;
KIRSI, VL ;
KOIVISTO, VA ;
GROOP, LC ;
GROOP, PH ;
ESCOBAR, F ;
JIMENEZ, FE ;
CAMPOSPASTOR, MM ;
MUNOZ, M ;
GOMEZ, M ;
MANGILI, R ;
POZZA, G ;
SPOTTI, D ;
HANSEN, KW ;
CHRISTIANSEN, JS ;
KLEIN, F ;
MOGENSEN, CE ;
VANDOORN, LG ;
SPOOREN, PFMJ ;
CRUICKSHANK, JK ;
JERVELL, J ;
PAUS, PN ;
COLLINS, A ;
WILLIAMS, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (04) :275-279
[20]  
Viberti Giancarlo, 1991, Journal of Diabetic Complications, V5, P72, DOI 10.1016/0891-6632(91)90022-H